Stalevo 50mg. 100mg. 150mg Tablet
PDF Leaflet Revision Date: 28 February 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of Parkinson's disease with end-of-dose motor fluctuations.
Dosage (summary)
Titrate to optimal dose; max 10 tablets/day.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Non-selective MAO inhibitors
- Antihypertensive medicines
- Dopamine receptor antagonists
Contraindications
- Hypersensitivity
- Severe hepatic impairment
- Narrow-angle glaucoma
- Pheochromocytoma
Common side effects
- Dyskinesias
- Nausea
- Diarrhoea
- Muscle pain
- Chromaturia
Counselling Points
- Take whole tablet
- Monitor for mental changes
- Avoid driving if drowsy
Serious warnings
- Risk of NMS
- Caution in cardiovascular disease
- May cause orthostatic hypotension
Important Disclaimer
The Stalevo 50mg. 100mg. 150mg Tablet professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
